Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 21, 2021 - Issue 3: Pharmacoeconomics in Oncology: Direct and Indirect Costs
Submit an article Journal homepage
3,946
Views
8
CrossRef citations to date
0
Altmetric
Original research

Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing

Clémence T. B. Pasmansa Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
,
Bastiaan B. J. Topsb Princess Máxima Center for Pediatric Oncology, Bilthoven, The NetherlandsView further author information
,
Elisabeth M. P. Steeghsc Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
,
Veerle M. H. Coupéd Department of Epidemiology and Biostatistics, Amsterdam University Medical Center, VU Amsterdam, Amsterdam, The NetherlandsView further author information
,
Katrien Grünbergc Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
,
Eiko K de Jongc Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
,
Ed M. D. Schuuringe Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsORCID Iconhttps://orcid.org/0000-0003-3655-143XView further author information
ORCID Icon,
Stefan M. Willemsf Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands;g PALGA Foundation, Houten, The NetherlandsView further author information
,
Marjolijn J. l. Ligtenbergc Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands;h Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
,
Valesca P. Retèli Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands;j Department of Health Technology and Services Research, University of Twente, Enschede, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-5624-3234View further author information
ORCID Icon,
Hans van Snellenbergk Hartwig Medical Foundation, Amsterdam, The NetherlandsView further author information
,
Ewart de Bruijnk Hartwig Medical Foundation, Amsterdam, The NetherlandsView further author information
,
Edwin Cuppenk Hartwig Medical Foundation, Amsterdam, The Netherlands;l Center for Molecular Medicine and Cancer Genomics Netherlands, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
&
Geert W. J. Frederixa Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsCorrespondence[email protected]
View further author information
 show all
Pages 413-414 | Received 03 Feb 2021, Accepted 12 Apr 2021, Published online: 06 May 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Martijn Simons, Michiel Van De Ven, Veerle Coupé, Manuela Joore, Maarten IJzerman, Erik Koffijberg, Geert Frederix, Carin Uyl - De Groot, Edwin Cuppen, Wim Van Harten & Valesca Retèl. (2021) Early technology assessment of using whole genome sequencing in personalized oncology. Expert Review of Pharmacoeconomics & Outcomes Research 21:3, pages 343-351.
Read now

Articles from other publishers (7)

Francisco Santos Gonzalez, Dylan Mordaunt, Zornitza Stark, Kim Dalziel, John Christodoulou & Ilias Goranitis. (2023) Microcosting diagnostic genomic sequencing: A systematic review. Genetics in Medicine 25:6, pages 100829.
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process 575 615 .
Edwin Cuppen, Olivier Elemento, Richard Rosenquist, Svetlana Nikic, Maarten IJzerman, Isabelle Durand Zaleski, Geert Frederix, Lars-Åke Levin, Charles G. Mullighan, Reinhard Buettner, Trevor J. Pugh, Sean Grimmond, Carlos Caldas, Fabrice Andre, Ilse Custers, Elias Campo, Hans van Snellenberg, Anna Schuh, Hidewaki Nakagawa, Christof von Kalle, Torsten Haferlach, Stefan Fröhling & Vaidehi Jobanputra. (2022) Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care. JCO Precision Oncology:6.
Crossref
Michiel van de Ven, Maarten IJzerman, Valesca Retèl, Wim van Harten & Hendrik Koffijberg. (2022) Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer. BMC Medical Research Methodology 22:1.
Crossref
Henri B. Wolff, Elisabeth M.P. Steeghs, Zakile A. Mfumbilwa, Harry J.M. Groen, Eddy M. Adang, Stefan M. Willems, Katrien Grünberg, Ed Schuuring, Marjolijn J.L. Ligtenberg, Bastiaan B.J. Tops & Veerle M.H. Coupé. (2022) Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands. JCO Precision Oncology:6.
Crossref
Simone N. Koole, Daan C. L. Vessies, Milou M. F. Schuurbiers, Astrid Kramer, Robert D. Schouten, Koen Degeling, Linda J. W. Bosch, Michel M. van den Heuvel, Wim H. van Harten, Daan van den Broek, Kim Monkhorst & Valesca P. Retèl. (2022) Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance. Cancers 14:7, pages 1783.
Crossref
Eva Berglund, Gisela Barbany, Christina Orsmark-Pietras, Linda Fogelstrand, Jonas Abrahamsson, Irina Golovleva, Helene Hallböök, Martin Höglund, Vladimir Lazarevic, Lars-Åke Levin, Jessica Nordlund, Ulrika Norèn-Nyström, Josefine Palle, Tharshini Thangavelu, Lars Palmqvist, Valtteri Wirta, Lucia Cavelier, Thoas Fioretos & Richard Rosenquist. (2022) A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias. Frontiers in Medicine 9.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.